Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 7/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 7/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 8/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.61 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.61 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.61 |
| ▸ | AR | P10275 | 2/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.61 |
| ▸ | IL6 | P05231 | 1/20 | 0.61 |
| ▸ | GLUL | P15104 | 1/20 | 0.61 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cloprednol SCHEMBL19327143 | 1.00 | PGR (1.00) | PGRNR3C1NR1I2MLNRADORA3 | |
| Cloprednol SCHEMBL11209368 | 1.00 | PGR (1.00) | PGRNR3C1NR1I2MLNRADORA3 | |
| Cloprednol SCHEMBL25308351 | 0.97 | PGR (0.95) | PGRNR3C1NR1I2MLNRADORA3 | |
| SCHEMBL11853459 | 0.90 | PGR (0.81) | PGRNR3C1NR1I2MLNRADORA3 | |
| SCHEMBL11853469 | 0.90 | PGR (0.81) | PGRNR3C1NR1I2MLNRADORA3 | |
| SCHEMBL11860993 | 0.89 | PGR (0.80) | PGRNR3C1NR1I2MLNRADORA3 | |
| SCHEMBL11860982 | 0.89 | PGR (0.80) | PGRNR3C1NR1I2MLNRADORA3 | |
| Cloprednol SCHEMBL3999177 | 0.84 | NR3C1 (0.71) | PGRNR3C1NR1I2MLNRADORA3 | |
| SCHEMBL11202047 | 0.83 | PGR (0.70) | PGRNR3C1NR1I2MLNRADORA3 | |
| SCHEMBL11202042 | 0.83 | PGR (0.70) | PGRNR3C1NR1I2MLNRADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7326 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4683679-A1 | METHOD FOR DIAGNOSING AND TREATING NIS-EXPRESSING CARCINOMAS AND METASTASES | NUSKE, Andreas (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-4301343-B1 | PHARMACEUTICAL COMPOSITIONS WITH REDUCED SIDE EFFECT AND METHODS OF USING THE SAME | TLC BIOPHARMACEUTICALS INC (US) | 2025-11-19 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-20250205227-A1 | METHODS FOR ADMINISTERING CORTICOSTEROIDS | SPARROW PHARMACEUTICALS, INC. | 2025-06-26 | — | — | US | claimed |
| WO-2025123147-A1 | TOLERIZING IMMUNOMODULATORY COMBINATION | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2025-06-19 | — | — | WO | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-05-08 | — | — | US | claimed |
| WO-2025076059-A1 | ROCAGLATE DERIVATIVES AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| EP-3943073-B1 | BIODEGRADABLE POLYMER MICROPARTICLE CONTAINING STEROID-BASED DRUG AND PREPARATION METHOD THEREFOR | REGENBIOTECH INC (KR) | 2025-03-26 | — | — | EP | claimed |
| EP-0173478-B1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1994-02-02 | — | — | EP | claimed |
| EP-0540751-A1 | STEROID COMPOUND COMBINED WITH POLYSACCHARIDE | Eisai Co., Ltd. (JP) | 1993-05-12 | — | — | EP | claimed |
| US-5192528-A | Encapsulated in liposomes, aerosols | LIPOSOME TECHNOLOGY, INC. (US) | 1993-03-09 | — | — | US | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |
| US-5049389-A | Non-phospholipd lipid, delivery by inhalation | LIPOSOME TECHNOLOGY, INC. (US) | 1991-09-17 | — | — | US | claimed |
| US-5043165-A | Cholesterol and salt; antiallergens, antiinflammatory agents, skin disorders | LIPOSOME TECHNOLOGY, INC. (US) | 1991-08-27 | — | — | US | claimed |
| WO-1990006775-A1 | A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS | LIPOSOME TECHNOLOGY, INC. (US) | 1990-06-28 | — | — | WO | claimed |
| US-4906476-A | Novel liposome composition for sustained release of steroidal drugs in lungs | LIPOSOME TECHNOLOGY, INC. | 1990-03-06 | — | — | US | claimed |
| EP-0173478-A1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1986-03-05 | — | — | EP | claimed |
| US-4051241-A | ANTIALLERGIC AGENTS, ANTIRHEUMATIC AGENTS, DERMATOLOGIC DRUGS ION | SYNTEX (U.S.A.) INC. (US) | 1977-09-27 | — | — | US | claimed |